The jury in Martin Shkreli’s securities fraud case has found the former pharmaceutical executive guilty on three counts related to a scheme in which he allegedly defrauded investors in two hedge funds and paid them back by pilfering another company he formed.
The jury of seven women and five men found him guilty on two counts of securities fraud and one count of conspiracy to commit securities fraud.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
